Multiples Social Networks Index
Tracks key publicly traded social networking and online community companies across the world
Explore index
๐ M&A multiples are live!
Check it out!
...
companies tracked
...
cumulative enterprise value
...
median EV/NTM revenue multiple
...
median NTM/LTM revenue growth
This chart shows the weighted market cap evolution over time, indexed to 0% at the beginning of the period
Loading index data...
Data as of October 3, 2025. Index data powered by FactSet and Morningstar, S&P 500 data sourced from Yahoo Finance.
This chart shows the weighted median evolution over time of key valuation metrics
Loading key metrics data...
This chart shows the regression relationship between valuation metrics across companies in the index
Loading valuation benchmarks...
Data as of October 3, 2025. Companies with EV multiples above 50x and y-axis values above 300% are considered non-meaningful and excluded from calculation.
This chart shows company rankings by selected metric within the index
Loading rankings data...
Data as of October 3, 2025. Companies with EV multiples above 50x are considered non-meaningful and excluded from calculation.
Compare key metrics between companies in the index
Comp 1 | Comp 2 | Comp 3 |
---|
Data as of October 3, 2025.
This chart shows the cumulative sum of selected metrics across all companies in the index over time
Loading cumulative data...
Similar to NASDAQ 100 Index, ๐ธ Multiples FemTech Index employs a modified market capitalization weighting scheme.
The weight process uses company-level weightss, which are derived using company enterprise value.
Company weights are evaluated based on two rules:
No companyโs weight may exceed 24%.
The aggregate weight of the companies whose weights exceed 4.5% may not exceed 48%.
If neither rule is 'violated', then no adjustments are made. Only in cases where either or both of the rules are 'violated', weight adjustments are made according to a two-stage adjustment process.
If no companyโs initial weight exceeds 24% of the Index, initial weights are used as Rule 1 weights without adjustment. Otherwise, initial weights are adjusted such that no companyโs weight may exceed 20% of the Index.
If the aggregate weight of the companies whose Rule 1 weights exceeds 4.5% and does not exceed 48%, Rule 1 weights are used as the final weights. Otherwise, Rule 1 weights are adjusted such that:
If the two-stage rule process results in a 'violation' of the weighting rules as previously detailed, then the process is repeated until the company weights meet the rule system.
Company | HQ | Stock Price | 1Y Perf. | Market Cap | EV/Revenue (LTM) | EV/Revenue (NTM) | Revenue Growth NTM/LTM | Gross Margin (NTM) | EBITDA Margin (NTM) | FCF Margin (NTM) | Rule of 40 |
---|---|---|---|---|---|---|---|---|---|---|---|
Grifols | Spain | EUR 11 | +15.8% | $8802.78096381864M | 2.1x | 2.0x | 6% | 40% | 25% | 7% | 31% |
Biomerieux | France | EUR 115 | +5.8% | $15889.286804398831M | 3.3x | 3.1x | 6% | 58% | 25% | 12% | 31% |
Hologic | United States of America | USD 68 | -17.1% | $15104.49344M | 3.9x | 3.7x | 5% | 60% | 33% | 26% | 37% |
Neurocrine Biosciences | United States of America | USD 137 | +21.8% | $13562.079677M | 4.9x | 4.2x | 16% | 98% | 24% | 25% | 37% |
Organon | United States of America | USD 11 | -44.2% | $2844.023434M | 1.8x | 1.8x | 0% | 61% | 31% | 13% | 31% |
QuidelOrtho | United States of America | USD 32 | -35.4% | $2168.061879M | 1.8x | 1.7x | 1% | 50% | 23% | 15% | 23% |
Lantheus Holdings | United States of America | USD 53 | -53.3% | $3582.61171M | 2.3x | 2.3x | 1% | 66% | 40% | 19% | 39% |
Neogen | United States of America | USD 6 | -66.0% | $1259.245537M | 2.3x | 2.5x | -5% | 48% | 20% | 5% | -40% |
Intellia Therapeutics | United States of America | USD 20 | -16.0% | $2194.170349M | 30.2x | 35.5x | -15% | NaN% | -838% | -712% | -737% |
Faes Farma | Spain | EUR 4 | +14.8% | $1573.5605415054902M | 2.5x | 2.1x | 14% | NaN% | 24% | 11% | 36% |
Celldex Therapeutics | United States of America | USD 26 | -23.9% | $1716.609162M | 254.6x | 369.9x | -31% | NaN% | -9494% | NaN% | -7442% |
Myriad Genetics | United States of America | USD 8 | -73.6% | $703.41738M | 0.9x | 0.9x | 4% | 70% | 4% | -2% | 7% |
Jiangsu Bioperfectus | China | CNY 64 | +6.9% | $755.7599232293983M | NaNx | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Curves Holdings Co. | Japan | JPY 812 | +10.7% | $498.8037318938896M | 1.9x | 1.8x | 8% | 41% | 23% | 14% | 32% |
InMode | United States of America | USD 15 | -12.1% | $977.213489M | 1.3x | 1.2x | 2% | 79% | 26% | 27% | 28% |
Olema Pharmaceuticals | United States of America | USD 11 | -18.0% | $764.586425M | n/a | 143.7x | n/a | 80% | -6367% | -5932% | n/a |
Alpha Teknova | United States of America | USD 6 | +27.9% | $329.118277M | 8.4x | 7.4x | 13% | 34% | -14% | -22% | -8% |
Achieve Life Sciences | United States of America | USD 3 | -33.5% | $163.024847M | n/a | 8.5x | n/a | 89% | NaN% | NaN% | n/a |
Trinity Biotech | United States of America | USD 1 | -5.5% | $3.949988M | 1.6x | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Biosynex | France | EUR 1 | -79.9% | $14.91760626774M | NaNx | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Insight Molecular | United States of America | USD 3 | +16.5% | $95.589961M | 25.4x | 21.3x | 19% | 60% | -695% | NaN% | -575% |
ImmuCell | United States of America | USD 7 | +72.2% | $59.250324M | NaNx | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Atossa Therapeutics | United States of America | USD 1 | -43.0% | $118.83771M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Elutia | United States of America | USD 1 | -76.6% | $38.041339M | 2.4x | 2.3x | 5% | 53% | -44% | NaN% | -51% |
Applied BioCode | Taiwan | TWD 23 | -0.8% | $75.94601770896888M | 5.0x | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Genoway | France | EUR 3 | -20.5% | $31.47526285056M | 1.8x | 1.6x | 12% | NaN% | 14% | -9% | 25% |
Veru | United States of America | USD 4 | -50.6% | $56.550513M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dare Bioscience | United States of America | USD 2 | -35.2% | $28.980929M | 67.4x | 1.6x | 4230% | NaN% | NaN% | NaN% | n/a |
Predilife | France | EUR 3 | -33.0% | $14.04746059638M | NaNx | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Novacyt | France | EUR 0 | -27.6% | $39.9463573887M | NaNx | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Futura Medical | United Kingdom of Great Britain and Northern Ireland | GBP 0 | -88.9% | $15.005833856M | 1.0x | 1.5x | -29% | NaN% | -50% | -47% | -97% |
Context Therapeutics | United States of America | USD 1 | -50.6% | $89.677282M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Movano | United States of America | USD 1 | -89.3% | $5.244892M | 3.4x | NaNx | NaN% | NaN% | NaN% | NaN% | n/a |
Stock prices as of October 3, 2025. Rule of 40 and revenue per FTE data is based on the last fiscal year. Financial data powered by Morningstar and FactSet.
Tracks key publicly traded social networking and online community companies across the world
Explore indexTracks publicly traded travel tech companies across both B2C (OTAs, metasearch, etc.) and B2B (travel management systems, B2B travel, etc.)
Explore indexTracks world's biggest and most impactful publicly traded console, PC and mobile gaming companies
Explore indexTracks publicly listed consumer subscription software (SaaS) companies, across all verticals (e.g. streaming, mobile apps, etc.)
Explore indexTracks key publicly traded semiconductor manufacturers and chipmakers
Explore indexTracks public AI companies across big tech AI conglomerates, chipmakers, robotics, autonomous AI, pure-play AI software, and vertical AI applications
Explore indexTracks public digital health companies across DTx, healthcare IT, healthcare software, telemedicine, fitness & wellness
Explore indexTracks publicly listed cybersecurity companies across network security, endpoint protection, identity management, cloud security, etc.
Explore indexTracks key publicly traded EV manufacturers, battery manufacturers, and EV charging companies
Explore indexTracks all European large cap tech companies (with market cap above $10B)
Explore indexTracks public DefenseTech companies across cybersecurity, weapons systems, autonomous tech, space technologies, etc.
Explore indexTracks publicly listed online classifieds companies across horizontal and vertical platforms (real estate, automotive, jobs, etc.)
Explore indexTracks key publicly traded online dating and matchmaking companies
Explore indexTracks key publicly traded automakers across mass market cars, premium cars, electric vehicles, commercial vehicles, etc.
Explore indexTracks key publicly listed B2B SaaS companies headquartered in Europe
Explore indexTracks medical device manufacturers with market cap above $1B, across all device categories
Explore indexTracks public cloud infrastructure companies across data & cloud infra, DevOps, developer tools, observability, etc.
Explore indexTracks all publicly traded tech companies operating across Latin American markets
Explore indexTracks top 100 publicly traded Chinese tech companies across software, consumer, semiconductors, fintech, and more
Explore indexTracks world's biggest and most impactful publicly listed tech companies
Explore indexTracks key publicly traded telecom service providers across the globe
Explore indexTracks all publicly traded airlines across all verticals (network carriers, low-cost carriers, regional airlines, cargo airlines, charter services, etc.)
Explore indexTracks 100 largest publicly traded Saudi Arabian companies across all sectors
Explore indexTracks publicly traded food delivery companies across restaurant delivery, quick commerce, ghost kitchens, meal kits, grocery delivery, etc.
Explore indexTracks all publicly traded online marketplaces across verticals (delivery, ridesharing etc.) and business models (classifieds, B2B, C2C etc.)
Explore indexGet access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.